TV-108

Nov
27

One Size Does Not Fit All: Using Population Pharmacokinetics for Tailored Hemophilia Care

In order to prevent and treat bleeding in patients with hemophilia A, the activity of the replaced clotting factor VIII must reach or exceed a target level over a period of time. Pharmacokinetic (PK) measures are therefore used to determine the dosing regimen of the different factor VIII replacement products. Recently, extended half-life recombinant factor […]

Read More
By Tom Meyers |
DETAIL